These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 795291)

  • 21. Enhanced IgE response to Candida albicans in postoperative invasive candidiasis.
    Savolainen J; Rantala A; Nermes M; Lehtonen L; Viander M
    Clin Exp Allergy; 1996 Apr; 26(4):452-60. PubMed ID: 8732243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early recovery of lymphocyte response to Candida after bone marrow transplantation in colonized patients.
    Tollemar J; Ringdén O
    Bone Marrow Transplant; 1991 Apr; 7(4):285-91. PubMed ID: 2070134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allergen presentation by epidermal Langerhans' cells from patients with atopic dermatitis is mediated by IgE.
    Mudde GC; Van Reijsen FC; Boland GJ; de Gast GC; Bruijnzeel PL; Bruijnzeel-Koomen CA
    Immunology; 1990 Mar; 69(3):335-41. PubMed ID: 2179131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell electrophoretic studies on the cellular immune response to Candida albicans in rabbits.
    Jenssen HL; Köhler H; Kaben U; Westphal HJ
    Sabouraudia; 1975 Jul; 13(2):123-31. PubMed ID: 1099697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Active and passive immunization against oral Candida albicans infection in a murine model.
    Farah CS; Ashman RB
    Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of anti-Candida antibodies in mice with gut colonization of Candida albicans.
    Tansho S; Abe S; Ishibashi H; Mitsuya M; Wada K; Ikeda T; Suegara N; Koshio O; Ono Y; Yamaguchi H
    Mediators Inflamm; 2004 Jun; 13(3):189-93. PubMed ID: 15223610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-Candida albicans precipitating antibodies in the sera of surgery patients.
    Marconi P; Bistoni F; Mosci L; Vecchiarelli A; Tissi L; Pitzurra A
    Boll Ist Sieroter Milan; 1977 Sep; 56(4):321-7. PubMed ID: 334194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of Candida albicans infection on the immunological response in mice].
    Jakoniuk P; Jablońska W; Borowski J
    Gruzlica; 1972; 40(12):1139-45. PubMed ID: 4567377
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunologic features of chronic granulomatous mucocutaneous candidiasis before and after treatment with transfer factor.
    Horsmanheimo M; Krohn K; Virolainen M; Blomqvist K
    Arch Dermatol; 1979 Feb; 115(2):180-4. PubMed ID: 426525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Values and limitations of the detection of circulating Candida antigen (Cand-Tec) in the diagnosis of deep candidiasis].
    Piens MA; Guyotat D; Pichot J; Mojon M
    Ann Biol Clin (Paris); 1987; 45(5):579-81. PubMed ID: 3425990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of the antibody response and antigenemia in anti-HIV positive subjects with or without candidiasis].
    Castelli L; Capra E; Gaido E; Milano R; Sampò A
    G Batteriol Virol Immunol; 1989; 82(1-12):101-7. PubMed ID: 2490391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of specific T-cell responses to Candida and tetanus antigens in partial DiGeorge syndrome.
    Davis CM; Kancherla VS; Reddy A; Chan W; Yeh HW; Noroski LM; Rosenblatt H; Shearer WT; Chinen J
    J Allergy Clin Immunol; 2008 Dec; 122(6):1194-9. PubMed ID: 18789819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defective handling of mannan by monocytes in patients with chronic mucocutaneous candidiasis resulting in a specific cellular unresponsiveness.
    Fischer A; Pichat L; Audinot M; Griscelli C
    Clin Exp Immunol; 1982 Mar; 47(3):653-60. PubMed ID: 6211308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies against glucan, chitin, and Saccharomyces cerevisiae mannan as new biomarkers of Candida albicans infection that complement tests based on C. albicans mannan.
    Sendid B; Dotan N; Nseir S; Savaux C; Vandewalle P; Standaert A; Zerimech F; Guery BP; Dukler A; Colombel JF; Poulain D
    Clin Vaccine Immunol; 2008 Dec; 15(12):1868-77. PubMed ID: 18971303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnosis of normal and abnormal delayed hypersensitivity to Candida albicans. Importance of evaluating lymphocyte activation by flow cytometry].
    Brunet JL; Peyramond D; Cozon GJ
    Allerg Immunol (Paris); 2001 Mar; 33(3):115-9. PubMed ID: 11386125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Predisposing factors in candidiasis. Animal experimental studies and clinical findings with special regard to immunity].
    Fegeler KJ
    Fortschr Med; 1978 Nov; 96(42):2169-72. PubMed ID: 361528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis.
    Fischer A; Ballet JJ; Griscelli C
    J Clin Invest; 1978 Nov; 62(5):1005-13. PubMed ID: 361754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of humoral and cellular immunity in lobomycosis.
    Pecher SA; Croce J; Ferri RG
    Allergol Immunopathol (Madr); 1979; 7(6):439-44. PubMed ID: 539528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cell electrophoretic studies in candida mycoses].
    Kaben U; Jenssen HL; Köhler H; Westphal HJ; Mix E
    Dermatol Monatsschr; 1976 Feb; 162(2):117-20. PubMed ID: 782938
    [No Abstract]   [Full Text] [Related]  

  • 40. Induction of the immune response suppression in mice inoculated with Candida albicans.
    Valdez JC; Mesón DE; Sirena A; de Petrino SF; Eugenia M; de Jorrat BB; de Valdex MG
    Mycopathologia; 1986 Mar; 93(3):147-50. PubMed ID: 3520329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.